Eurofins Scient. Shares Climb 2.5%, Defying a Retreating CAC 40
The Luxembourg-based bioanalytical testing specialist stands out at midday in a sharply retreating CAC 40. The stock benefits from a favorable rotation as the Paris market absorbs the downturn in semiconductors and automotive sectors. The value climbs to the top ranks of the flagship index.
Eurofins Scient. Among the Top Gainers in a Heavy CAC 40 Market
Eurofins Scient. shares gain 2.33% to €64.96, while the CAC 40 drops 0.78% to 8,334 points and the SBF 120 falls by 0.79%. The stock is among the top gainers in the CAC 40, going against a market weighed down by STMicroelectronics (-7.23%), Renault (-5.07%), and Schneider Electric (-4.12%). The session unfolds in a climate of increased volatility, with the VIX jumping 18.18% to 19.83, amid ongoing tensions around the Strait of Hormuz and a more restrictive tone from major central banks. This movement follows the June 4 rebound, which had already allowed the stock to break through a watched technical resistance, as mentioned in a previous brief. Over three months, the stock has gained 6.35%, and 9.18% over a year.
Price Moves Above Moving Averages Despite Cautious View from BofA
In terms of indicators, the price now moves above its three moving averages: the MM20 at €63.22 (+2.75%), the MM50 at €62.65 (+3.69%), and the MM200 at €63.19 (+2.80%). The RSI at 53 remains neutral, leaving room before approaching the resistance identified at €65.42, now close to today's price. Regarding analyst opinions, BofA Securities yesterday raised its price target from €56 to €58 while maintaining its sell rating, implying a potential downside of nearly 11% from the current price. This cautious stance contrasts with today's stock market dynamics. The next technical milestone to watch is the €65.42 threshold, whose crossing would determine whether or not the bullish movement that began in early June continues.
